MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-03+40,000→ 40,000 totalExercise: $7.77From: 2021-01-03Exp: 2030-01-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.